Sacubitril/valsartan alleviates sunitinib-induced cardiac fibrosis and oxidative stress via improving TXNIP/TRX system and downregulation of NF-ĸB/Wnt/β-catenin/SOX9 signaling
Hoda E. Mohamad, Mervat E. Askar, Mohamed A. Shaheen, Nourhan M. Baraka, Yasmin K. Mahmoud
Topics & Concepts
TXNIPValsartanOxidative stressSunitinibMedicineWnt signaling pathwayThioredoxin-Interacting ProteinPharmacologyCancer researchRANKLDownregulation and upregulationEndocrinologyInternal medicineChemistryThioredoxinSignal transductionCancerBlood pressureBiochemistryActivator (genetics)GeneReceptorInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisCardiac Fibrosis and RemodelingChemotherapy-induced cardiotoxicity and mitigation